Please login to the form below

Not currently logged in

NICE reserves its rejection of Eisai’s Lenvima


The cost-effectiveness watchdog has now backed the thyroid cancer treatment

MHRA suspends new prescriptions of fibroid drug Esmya

Gedeon Richter buildingThe delay to Gedeon Richter's therapy follows reports of serious liver damage in some patients

AZ bags key lung cancer approval for Imfinzi

AstraZeneca AZBecomes the first PD-1/PD-L1 inhibitor approved to treat inoperable stage III NSCLC patients

J&J’s Erleada first US drug for non-metastatic prostate cancer

Drug approved by the FDA on the back of data from the SPARTAN study

Pfizer files third-gen ALK inhibitor for lung cancer

The US FDA is set to make a decision on lorlatinib later this year

NICE backs Roche’s Gazyvaro after initial rejection

Roche Basel SwitzerlandAn undisclosed discount swayed the cost-effectiveness body

NICE backs EUSA's RCC treatment Fotivda

EUSA PharmaThe UK’s cost-effectiveness watchdog recommends its first-line use

FDA hands GSK a reprieve by blocking Novartis generic

GSK - logo on buildingThe Advair rival could be delayed until 2019

Roche’s lung drug Esbriet reserved for worse cases, says NICE

Boehringer Ingelheim’s Ofev subject to same conditions

KeysMoving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018